Researchers Archit Agarwal (20) and Harry Sehrawat (19) at IIT Delhi incubated startup Sanfe have designed a solution for women daily routine due to period pain.
IIT Delhi Professor Dr. Srinivasan Venkataraman, Department of Design also part of Sanfe to reach the goal and providing comfort to women without any side effect. He said, “Women comprise close to 50% of our population and a significant portion of this population experiences pain and cramps during the menstrual period. Therefore, this becomes an important problem to solve.”
On the event of International Women’s Day, two young men from the Indian Institute of Technology (IIT), Delhi propelled ‘Sanfe period pain relief roll-on’ to ease period’s agony and calm out the mood swing by women during menstruation cycle.
Sanfe is an essential oil-based natural formulation which can be applied on cramp affected regions, for example, the lower midriff, back and legs and so on. It creates warm-cool sensation treatment. It first cools the skin and later warms it which helps the muscles and resolves cramps. It will be available in a 10 ml bottle which keeps going to three months and costs Rs 169 and for single day use cost Rs 10.
The pair also called as women strengthening business visionaries, made ‘Sanfe stand and pee’ product a year ago which enabled women to stand and pee utilizing a glass-like product and sparing them from contacting any filthy toilet. ‘Stand and pee’ came to them when their companion experienced urinary tract disease (UTI) from utilizing open washrooms.
The idea for their most recent product, period-pain relief roll-on came to them when their peers couldn’t study during exam hours because of high-force period pains. Conversing with indianexpress.com, Agarwal stated, “We talk about women empowerment but basic issues that stop women from getting a fair chance in life often get neglected. During our research, we found that period of pain forces over 40 per cent of women to miss their daily routine”
Both are seeking after BTech from IIT Delhi and are in their last year of their engineering. Pushing forward as well, they need to create innovation for ‘social change’.
As a part of their R&D, the team also conducted trials on women after ethical approval from AIIMS, New Delhi. The product currently is now FDA approved.